Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Scandinavian Cardiovascular Journal : SCJ|March 28, 2008
Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular functionFolke Rönn, Milos Kesek, Niklas Höglund, et al.Stapp Car Crash Journal|January 19, 2007
Injury tolerance and response of the ankle joint in dynamic dorsiflexionRodney Rudd, Jeff Crandall, Steven Millington, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2006
Reduction of fluoroscopy duration in radiofrequency ablation obtained by the use of a non-fluoroscopic catheter navigation systemMilos Kesek, Niklas Wallenius, Folke Rönn, et al.Upsala Journal of Medical Sciences|October 10, 2013
U22 protocol as measure of symptomatic improvement after catheter ablation of atrial fibrillationNiklas Höglund, Folke Rönn, Titti Tollefsen, et al.Upsala Journal of Medical Sciences|March 15, 2017
Cardioversion of atrial fibrillation does not affect obstructive sleep apneaNiklas Höglund, Carin Sahlin, Milos Kesek, et al.Upsala Journal of Medical Sciences|November 17, 2010
Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22Milos Kesek, Folke Rönn, Titti Tollefsen, et al.Pacing and Clinical Electrophysiology : PACE|March 3, 2009
U22, a protocol to quantify symptoms associated with supraventricular tachycardiaMilos Kesek, Titti Tollefsen, Niklas Höglund, et al.Thrombosis Research|January 18, 2011
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversionJonas Andersson, Henrik Almroth, Niklas Höglund, et al.European Heart Journal|February 10, 2009
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre studyHenrik Almroth, Niklas Höglund, Kurt Boman, et al.International Journal of Cardiology|June 19, 2012
The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatinNiklas Höglund, Jonas Andersson, Henrik Almroth, et al.Pageof 2